Fragile X Syndrome

Fragile X syndrome is caused by an expanded CGG repeat (> 200 repeats) in the 5' untranslated portion of the fragile mental retardation 1 gene (FMR1) within the X chromosome, leading to deficiency of fragile X mental retardation protein (FMRP). It is cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. Intellectual disability occurs in nearly all males and roughly 50% of females with the full mutation. Discover the latest research on Fragile X syndrome here.

October 22, 2020
Open Access

Selective role of the translin/trax RNase complex in hippocampal synaptic plasticity

Alan Jung ParkTed Abel
October 27, 2020
Open Access

Decreased FMR1 mRNA levels found in men with substance use disorders

Maria KrastevaBoryan Andreev
September 23, 2020
Open Access

Facilitating individuals and families affected by fragile X syndrome to participate in medication trials

Journal of Intellectual Disability Research : JIDR
S E A EleyA C Stanfield
October 23, 2020
Open Access

Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability

Carol L Wilkinson, C. A. Nelson
September 28, 2020
Open Access

Drug REpurposing using AI/ML tools - for Rare Diseases (DREAM-RD): A case study with Fragile X Syndrome (FXS)

BioRxiv : the Preprint Server for Biology
K. Agastheeswaramoorthy, Aarti Sevilimedu
September 24, 2020
Open Access

Replication Stress Induces Global Chromosome Breakage in the Fragile X Genome

Cell Reports
Arijita ChakrabortyWenyi Feng
October 22, 2020

Interregulation between Fragile X Mental Retardation Protein and Methyl CpG Binding Protein 2 in the Mouse Posterior Cerebral Cortex

Human Molecular Genetics
Jason ArsenaultDavid R Hampson
September 20, 2020
Open Access

New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein

International Journal of Molecular Sciences
Fumio SakaneChiaki Murakami
October 23, 2020
Open Access

The Fragile X Mental Retardation Protein regulates RIP1K and colorectal cancer resistance to necroptosis

Cellular and Molecular Gastroenterology and Hepatology
Antonio Di GraziaIvan Monteleone
September 26, 2020
Open Access

FMR1 loss in a human stem cell model reveals early changes to intrinsic membrane excitability

Developmental Biology
Sara G SuscoLindy E Barrett
October 13, 2020
Open Access

Increased aperiodic gamma power in young boys with Fragile X is associated with better language ability

MedRxiv : the Preprint Server for Health Sciences
Carol L Wilkinson, C. A. Nelson
October 24, 2020
Open Access

Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice

Scientific Reports
Patricia CogramMichael Tranfaglia
October 23, 2020
Open Access

DNA Methylation at Birth Predicts Intellectual Functioning and Autism Features in Children with Fragile X Syndrome

International Journal of Molecular Sciences
Claudine M KraanDavid E Godler
September 29, 2020

The effect of fecal microbiota transplantation on autistic-like behaviors in Fmr1 KO mice

Life Sciences
Nayeon GooJong Hoon Ryu
September 29, 2020
Open Access

Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction

Frontiers in Cell and Developmental Biology
Cara J WestmarkYoshihiro Kawaoka
October 1, 2020
Open Access

Fragile X Mental Retardation Protein modulates somatic D-type K+ channels and action potential threshold in the mouse prefrontal cortex

Journal of Neurophysiology
Brian E Kalmbach, Darrin H Brager

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.


Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Adult Polyglucosan Body Disease

Adult polyglucosan body disease (APBD) is a rare autosomal recessive disease characterized by defects in the glycogen brancher enzyme 1 (GBE1) gene. Discover the latest research on APBD here.

Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

© 2020 Meta ULC. All rights reserved